Eikon Therapeutics, Inc. (EIKN)
9.21
-1.52
(-14.17%)
USD |
NASDAQ |
Sep 10, 16:00
9.19
-0.02
(-0.22%)
After-Hours: 04:40
Eikon Therapeutics Market Cap : 498.71M for Sept. 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 10, 2026 | 498.71M |
| September 09, 2026 | 581.02M |
| September 08, 2026 | 579.93M |
| September 04, 2026 | 588.06M |
| September 03, 2026 | 593.47M |
| September 02, 2026 | 616.21M |
| September 01, 2026 | 589.14M |
| August 31, 2026 | 566.40M |
| August 28, 2026 | 594.55M |
| August 27, 2026 | 623.80M |
| August 26, 2026 | 648.70M |
| August 25, 2026 | 679.57M |
| August 24, 2026 | 604.30M |
| August 21, 2026 | 616.76M |
| August 20, 2026 | 582.10M |
| August 19, 2026 | 650.33M |
| August 18, 2026 | 630.83M |
| August 17, 2026 | 566.94M |
| August 14, 2026 | 598.35M |
| August 13, 2026 | 559.36M |
| August 12, 2026 | 564.23M |
| August 11, 2026 | 553.94M |
| August 10, 2026 | 526.77M |
| August 07, 2026 | 502.95M |
| August 06, 2026 | 498.62M |
| Date | Value |
|---|---|
| August 05, 2026 | 517.02M |
| August 04, 2026 | 517.56M |
| August 03, 2026 | 495.37M |
| July 31, 2026 | 498.62M |
| July 30, 2026 | 520.81M |
| July 29, 2026 | 487.79M |
| July 28, 2026 | 513.78M |
| July 27, 2026 | 534.89M |
| July 24, 2026 | 481.83M |
| July 23, 2026 | 520.81M |
| July 22, 2026 | 520.27M |
| July 21, 2026 | 536.51M |
| July 20, 2026 | 522.44M |
| July 17, 2026 | 528.93M |
| July 16, 2026 | 538.68M |
| July 15, 2026 | 532.72M |
| July 14, 2026 | 551.67M |
| July 13, 2026 | 565.21M |
| July 10, 2026 | 572.79M |
| July 09, 2026 | 607.44M |
| July 08, 2026 | 580.37M |
| July 07, 2026 | 628.01M |
| July 06, 2026 | 651.29M |
| July 02, 2026 | 678.90M |
| July 01, 2026 | 663.20M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.775B |
| Alnylam Pharmaceuticals, Inc. | 33.10B |
| Anika Therapeutics, Inc. | 280.91M |
| Savara, Inc. | 1.093B |
| Vericel Corp. | 1.938B |
Market Cap Related Metrics
| PEG Ratio | -0.0101 |
| Price to Book Value | 1.069 |
| Price | 9.21 |
| Earnings Yield | -71.44% |
| PEGY Ratio | -0.0101 |